Juul gets OK to sell updated vaping device with age-gating technology
Juul Labs has been granted federal approval to sell an updated version of its e-cigarette, featuring an optional age-verification system aimed at preventing underage access. This marks the first update to the product since its launch over a decade ago. The company faces ongoing challenges, having laid off many workers and paid nearly $3 billion to resolve legal issues related to youth vaping. The new model, named Juul2, will include updated tobacco and menthol-flavored cartridges, though the company aims to expand its flavor options for adult users. While the FDA's decision does not endorse the product, it acknowledges that switching to e-cigarettes could reduce exposure to harmful cigarette chemicals. The FDA has approved some e-cigarettes for adult smokers, reflecting a policy change influenced by industry lobbying. However, Juul is now the second-largest e-cigarette brand in the U.S., behind Vuse, and teen usage has declined, with many younger vapers turning to unregulated Chinese-made devices.
Juul Labs has been granted federal approval to sell an updated version of its e-cigarette, featuring an optional age-verification system aimed at preventing underage use. The decision was announced on Friday by the Food and Drug Administration (FDA), allowing the company to reintroduce a new model of its flagship product for the first time in over a decade. This marks a significant step for Juul, which has faced intense scrutiny and legal challenges related to its role in the surge of youth vaping during the early 2010s. The updated device will be marketed under the brand name Juul2, accompanied by revised versions of its tobacco- and menthol-flavored cartridges. In 2019, Juul discontinued several popular flavors, including mango, mint, and creme, which had driven much of its sales but were also associated with widespread teenage use. The company has since pivoted toward targeting adult consumers, aiming to position itself as a tool for smoking cessation rather than a product for youth appeal. In a statement, Juul's CEO, K.C. Crosthwaite, expressed the company's intent to expand its flavor offerings beyond tobacco and menthol, focusing on options tailored for adult nicotine users. The FDA emphasized that the approval does not constitute an endorsement of e-cigarettes, and reiterated that individuals who do not smoke should avoid using Juul or similar products. However, the agency noted that smokers who transition entirely to Juul may experience reduced exposure to harmful substances found in conventional cigarettes. Company studies reviewed by the FDA indicate that between 20% and 50% of smokers who used Juul products were able to quit smoking within six weeks. These success rates varied depending on the specific flavors and nicotine levels utilized. The new device introduces an optional feature requiring users to complete an online age verification process through a mobile application before accessing the product. This development aligns with broader regulatory changes, as the FDA has previously approved a limited number of e-cigarettes for aiding adult smokers in quitting or reducing cigarette consumption. Notably, in May, the agency cleared the first fruit-flavored electronic cigarettes intended for adult users, a move that signaled a shift in policy following sustained advocacy efforts from the vaping industry. Currently, Juul is no longer the leading e-cigarette brand in the United States, having been overtaken by Vuse, which is produced by Reynolds American, a subsidiary of the larger Altria Group. Reynolds American also manufactures well-known brands such as Camel and Newport cigarettes. Federal data reveals a decline in overall vaping among teenagers, with many opting instead for unregulated disposable e-cigarettes sourced from China. These devices often come in appealing fruit and candy flavors, continuing to attract younger users despite ongoing public health concerns. The FDA's decision reflects both regulatory caution and industry pressure, balancing the need to curb youth access with the potential benefits of e-cigarettes as alternatives to combustible tobacco products. As Juul moves forward with its new offering, the focus will remain on compliance with age restrictions and the continued monitoring of public health outcomes. The long-term impact of these changes on both adolescent vaping trends and adult smoking cessation efforts remains to be seen.
Go to the primary sources (4)
The official sources this coverage is built on. Read them directly to bypass framing.
Juul Labs has been granted federal approval to sell an updated version of its e-cigarette, featuring an optional age-verification system aimed at preventing underage access. This marks the first update to the product since its launch over a decade ago. The company faces ongoing challenges, having laid off many workers and paid nearly $3 billion to resolve legal issues related to youth vaping. The new model, named Juul2, will include updated tobacco and menthol-flavored cartridges, though the company aims to expand its flavor options for adult users. While the FDA's decision does not endorse the product, it acknowledges that switching to e-cigarettes could reduce exposure to harmful cigarette chemicals. The FDA has approved some e-cigarettes for adult smokers, reflecting a policy change influenced by industry lobbying. However, Juul is now the second-largest e-cigarette brand in the U.S., behind Vuse, and teen usage has declined, with many younger vapers turning to unregulated Chinese-made devices.
Bias read (Center): The article presents factual information about regulatory decisions regarding vaping products, including the FDA's role and corporate actions. It avoids overtly biased language, provides context about legal and health considerations, and mentions both corporate and governmental perspectives without顯
Juul Labs has been granted federal approval to sell an updated version of its e-cigarette, featuring an optional age-verification system to curb underage use. This marks the first update to the product since its launch over a decade ago. The company has faced significant financial penalties, including paying approximately $3 billion to resolve lawsuits related to teen usage. Juul plans to introduce the new device as 'Juul2' with updated flavored cartridges, moving away from previously popular teen-friendly flavors like mango and mint. The FDA notes that switching to Juul could reduce exposure to harmful chemicals compared to traditional cigarettes, though it cautions non-smokers against using e-cigarettes. The approval reflects broader regulatory changes allowing fruit-flavored e-cigarettes for adults, despite Juul no longer being the leading brand in the U.S.
Bias read (Center): The article presents a balanced view of Juul's regulatory status, its financial liabilities, and public health implications without overtly favoring either side. It reports on FDA decisions, legal settlements, and market shifts without clear ideological slant.
Juul Labs has been granted U.S. federal permission to sell an updated version of its vaping device, which includes an optional age-verification system to prevent underage use. This marks the first update to the product since its launch over a decade ago. The company has faced significant challenges, including layoffs and a $3 billion settlement over lawsuits related to teen usage. The new device, called Juul2, comes with updated tobacco- and menthol-flavored cartridges, though some fruit and candy flavors were discontinued in 2019 due to concerns about youth appeal. While the FDA notes that switching entirely to Juul can reduce exposure to harmful chemicals compared to traditional cigarettes, it warns that non-smokers should not use e-cigarettes. The agency has approved a few e-cigarettes for helping adults quit smoking, reflecting a broader regulatory shift.
Bias read (Center): The article presents information about Juul's regulatory status and product updates without overtly favoring either pro-industry or anti-industry perspectives. It includes both positive outcomes (FDA approval, potential harm reduction) and negative aspects (lawsuit settlements, youth targeting). The
How each side covered it
The same event, grouped by the political lean of the outlets covering it.
progressive
center
conservative
★
How each side covered it
Support independent, bias-aware news and unlock the social pulse, community voting, and every other Supporter feature.
United States
